← Leaderboards
Daniel Larach
Vanderbilt University Medical Center
$526,926
Attributed
$526,926
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $175.7K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$526,926 · 1
By mechanism
K23$526,926 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Ashley A Leech$860,388
- Macrae F Linton$20,130,632
- Charles F Caskey$11,868,563
- Jonathan Dale Casey$4,195,060
Others in their field
Other Rising Stars on “Absence Of Pain Sensation”
- Sid Ahmed Labed · Evodenovo, Inc.$2,230,338
- James N Bates · Atelerix Life Sciences Inc.$1,836,983
- Cameron Reid Smith · University Of Florida$1,762,231
- Katharina Maria Busl · University Of Florida$1,762,231
- Grace Lim · University Of Pittsburgh At Pittsburgh$1,677,192
- Alejandra Mendoza · Scripps Research Institute, The$1,656,000
Research focus
Absence Of Pain SensationAcceptability And FeasibilityAcute PainAbuse LiabilityAmericanAnalgesicsAntagonistAuthorityAdverse EffectsBiometryBuprenorphineCareerCareer DevelopmentCaringCessation Of LifeChadChronic PainClinical DatabaseClinical InvestigatorClinical PainClinical SciencesClinical Trials DesignCrossover DesignDesign
Grant awards (3)
Low-dose buccal buprenorphine: Relative abuse potential and postoperative analgesic acceptability$175,681
K23 · FY2025 · DA · contact PI
Low-dose buccal buprenorphine: Relative abuse potential and postoperative analgesic acceptability$175,681
K23 · FY2024 · DA · contact PI
Low-dose buccal buprenorphine: Relative abuse potential and postoperative analgesic acceptability$175,564
K23 · FY2023 · DA · contact PI